AJP - Endocrinology and Metabolism, Vol 272, Issue 1 E155-E162, Copyright © 1997 by American Physiological Society

ARTICLES

Measurement of hepatic Ra UDP-glucose in vivo in rats: relation to glycogen deposition and labeling patterns

M. K. Hellerstein, A. Letscher, J. M. Schwarz, D. Cesar, C. H. Shackleton, S. Turner, R. Neese, K. Wu, S. Bock and S. Kaempfer
Department of Nutritional Sciences, University of California, Berkeley 94720-3104, USA.

We previously described an isotopic method for quantifying the rate of appearance of hepatic UDP-glucose (Ra UDP-Glc) and the direct entry of glucose into hepatic UDP-Glc in humans. Here, the method is tested in depth in rats. The basic principles are that dilution of labeled galactose in hepatic UDP-Glc, sampled noninvasively by the xenobiotic glucuronate (GlcUA) method, reveals Ra UDP-Glc. First, labeling patterns in secreted acetaminophen-GlcUA were compared with hepatic glycogen and plasma glucose by use of mass isotopomer distribution analysis from [2-(13)C]glycerol. Labeling was consistent with common precursor pools of glucose 6-phosphate and triose-phosphate for all end products studied in fasted and in intravenous glucose- and fructose-infused states. Next, [1-(3)H]galactose was administered. After a 24-h fast, Ra UDP-Glc was 25.0 +/- 1.7 mumol.kg body wt-1.min-1 and rose to 57.7 and 72.7 mumol.kg-1.min-1 at intravenous glucose infusion rates of 111 and 167-194 mumol.kg-1.min-1, respectively. Liver glycogen deposition correlated closely with Ra UDP-Glc (R2 = 0.76), although the turnover value was approximately 50% higher than the net deposition rate. In conclusion, the turnover of an intrahepatic metabolite, UDP-Glc, can be measured noninvasively, and Ra UDP-Glc correlates with liver glycogen deposition in rats.

This article has been cited by other articles:

				S. F. Previs, G. W. Cline, and G. I. Shulman A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo Am J Physiol Endocrinol Metab, July 1, 1999; 277(1): E154 - E160. [Abstract] [Full Text] [PDF]

				S. Q. Siler, R. A. Neese, M. P. Christiansen, and M. K. Hellerstein The inhibition of gluconeogenesis following alcohol in humans Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E897 - E907. [Abstract] [Full Text] [PDF]

				M. Flores-Diaz, A. Alape-Giron, B. Persson, P. Pollesello, M. Moos, C. von Eichel-Streiber, M. Thelestam, and I. Florin Cellular UDP-Glucose Deficiency Caused by a Single Point Mutation in the UDP-Glucose Pyrophosphorylase Gene J. Biol. Chem., September 19, 1997; 272(38): 23784 - 23791. [Abstract] [Full Text] [PDF]

				T. H. van Dijk, F. H. van der Sluijs, C. H. Wiegman, J. F. W. Baller, L. A. Gustafson, H.-J. Burger, A. W. Herling, F. Kuipers, A. J. Meijer, and D.-J. Reijngoud Acute Inhibition of Hepatic Glucose-6-phosphatase Does Not Affect Gluconeogenesis but Directs Gluconeogenic Flux toward Glycogen in Fasted Rats. A PHARMACOLOGICAL STUDY WITH THE CHLOROGENIC ACID DERIVATIVE S4048 J. Biol. Chem., July 6, 2001; 276(28): 25727 - 25735. [Abstract] [Full Text] [PDF]